SCHEMBL8684341

SCHEMBL8684341

FC(F)(F)c1cccc(-c2cc3[nH]ccn3n2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.48
KDM4E B2RXH2 2/20 0.47
ALDH1A1 P00352 2/20 0.47
LMNA P02545 1/20 0.46
SCN2A Q99250 2/20 0.45
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
GABRA1 P14867 1/20 0.44
HPGD P15428 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
GABRA2 P47869 1/20 0.44
HSD17B10 Q99714 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
KMO O15229 2/20 0.43
XDH P47989 1/20 0.43
F2RL3 Q96RI0 1/20 0.43
CTSS P25774 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8684139 0.85 RAD51 (0.39) SCN2AF2RL3
SCHEMBL2265845 0.81 PARP1 (0.42) KDM4EALDH1A1HPGDHSD17B10TDP1
SCHEMBL4047695 0.75 IDO1 (0.46) IDO1KDM4EALDH1A1LMNASCN2A
SCHEMBL8684313 0.74 CA12 (0.41) KDM4EALDH1A1LMNA
SCHEMBL1348539 0.73 KDM4E (0.49) IDO1KDM4EALDH1A1LMNACYP1A2
SCHEMBL8684094 0.71 SMN1; SMN2 (0.42) KDM4EALDH1A1LMNAHPGDHSD17B10
SCHEMBL13733242 0.71 ALDH1A1 (0.52) IDO1KDM4EALDH1A1LMNACYP1A2
SCHEMBL9383785 0.71 KDM4E (0.56) IDO1KDM4EALDH1A1LMNACYP1A2
SCHEMBL10850137 0.70 KDR (0.59) KDM4EALDH1A1LMNACYP1A2CYP3A4
Hydrochloric Acid SCHEMBL8685739 0.70 TLR8 (0.47) IDO1KDM4EALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5723481-A ANTIULCER AGENTS AND 5-LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-03-03 US disclosed
US-5698576-A POSSESS ANTI-ULCER AND 5-LIPOXYGENASE INHIBITORY ACTIVITIES SANKYO COMPANY, LIMITED (JP) 1997-12-16 US disclosed
US-5665752-A LIPOXYGENASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1997-09-09 US disclosed
US-5354768-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY, LIMITED (JP) 1994-10-11 US disclosed
EP-0353047-B1 Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO CO (JP) 1994-10-05 EP disclosed
US-5308542-A Stability, heat and electrical resistance; dielectic anisotropy MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1994-05-03 US disclosed
US-5232939-A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents SANKYO COMPANY LIMITED (JP) 1993-08-03 US disclosed